Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03251079 · ClinicalTrials.gov registry record · NA
PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm
A NA study, sponsored by Senseonics.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT03251079 is a NA study that has completed, run by Senseonics. The registered enrollment target is 36 participants.
The verdict
NCT03251079, a NA study, has completed, sponsored by Senseonics.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this multi-center, prospective clinical study is to evaluate the performance of a novel, implanted Senseonics continuous glucose monitoring system (Senseonics CGM System) compared to Yellow Springs Instrument (YSI) glucose analyzer reference standard measurements using a next generation transmitter and algorithm. Other measures evaluated will be the effects of compression on performance and the safety of the Senseonics CGM system.
Interventions
- DEVICE Continuous glucose monitoring system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2017-07-25 |
| Est. Completion | 2018-02-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03251079
The ClinicalTrials.gov registry entry for NCT03251079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Senseonics, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous glucose monitoring system is the first listed.
NCT03251079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03251079 about?
NCT03251079 is a clinical study titled "PRECISION Study: Multi-center Study of Performance of a Novel Implanted CGM System Using a Next Generation Transmitter and Algorithm". The purpose of this multi-center, prospective clinical study is to evaluate the performance of a novel, implanted Senseonics continuous glucose monitoring system (Senseonics CGM System) compared to Yellow Springs Instrument (YSI) glucose analyzer reference standard measurements using a next generati...
What is the current status of trial NCT03251079?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2017-07-25. Estimated completion is 2018-02-01.
What interventions are being tested in trial NCT03251079?
The interventions under investigation include: Continuous glucose monitoring system (DEVICE).
Who is sponsoring clinical trial NCT03251079?
This trial is sponsored by Senseonics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.